SAN DIEGO, May 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal third quarter ended March 31, 2024, and recent corporate developments.

Joined John Deere supply base and chosen to deploy DriveMod Tuggers to Dubuque, IA operation.Renewed contract with US Continental, unveiling a study that found Cyngn's autonomous vehicles yielded 4x efficiency gain.Announced initial deployment with Rivian.Announced strategic partnership with RobotLAB, expanding the Cyngn Distributor Network.Aligned with Nvidia to power DriveMod's artificial intelligence.Attended MODEX with Motrec, premiering the DriveMod Tugger autonomous MT-160. Secured our 19th granted US patent.Launched our "auto-unhitch" feature, enabling DriveMod Tuggers to drop off carts without requiring any human intervention.MENLO PARK, Calif., May 16, 2024 /PRNewswire/ -- Cyngn Inc. (the "Company" or "Cyngn") (Nasdaq: CYN) today shared several commercial and technological accomplishments ...

Brand Engagement Network Inc. (“BEN”) (Nasdaq: BNAI), an emerging provider of personalized customer engagement AI, today announced its financial results and key business highlights for the first quarter ended March 31st, 2024.

Lucid strengthens balance sheet and secures a July 17, 2024 MolDX pre-submission meeting date Veris Health completes MOU with The Ohio State's James Cancer Hospital Conference call and webcast to be held tomorrow, May 14th at 8:30 AM EDT NEW YORK, May 13, 2024 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the Company for ...